Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 IV methylnaltrexone for postoperative ileus after colectomy
2006-006383-29Phase 3Completed
- Sponsor
- Progenics Pharmaceuticals
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative ileus (POI) comparing IV methylnaltrexone bromide with Placebo IV infusion (2 arms). Primary endpoint: Time to first bowel movement from end of surgery. Started May 2007; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on 2006-006383-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006383-29.